Top Stories

Jefferies is conducting the process for the Detroit-based business, which makes, sells, monitors and installs tech-enabled ignition interlock and alcohol monitoring devices.

A sizable network of mental health and addiction treatment centers hits the market via Moelis and Jefferies as demand for behavioral health services, accelerated by the pandemic, is on the rise.

Specialty Sales, which provides products and services to help prevent hoof disease among dairy farm herds, is set to become a $10 million-plus EBITDA platform.

The firm has injected $77m into Atera, joining K1 Investment Management as an investor and pushing the IT services company's valuation to $500m.

Dental365 marks the third dental-related investment to date for TJC, which also currently owns dental supplier Young Innovations and previously backed Zest Anchors, a manufacturer of overdenture attachments.

Representing the first autism-treatment platform to trade hands in a year-and-a-half, Cerberus joins the long list of private equity firms injecting capital into the fragmented space.

Smile Doctors, the largest orthodontics-focused DSO in the US, has grown EBITDA by around 5x since the healthcare-focused PE firm backed the business in late 2017.

Bain preempts a sale process for PartsSource, eager to invest behind a fast-growing technology business helping hospitals run more smoothly by improving supply chain inefficiencies.

The firm will generate a 31% IRR through the sale of the metal processing company.

As PE firms have gotten more sophisticated, they’ve deployed more capital than ever before, despite what remains a complex pandemic environment, says EY’s PE analyst.